Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 2
1957 1
1959 5
1960 2
1962 3
1964 2
1965 2
1966 3
1967 5
1968 6
1969 8
1970 10
1971 5
1972 9
1973 11
1974 5
1975 8
1976 10
1977 13
1978 10
1979 10
1980 11
1981 6
1982 14
1983 10
1984 12
1985 12
1986 17
1987 21
1988 24
1989 24
1990 26
1991 24
1992 31
1993 42
1994 54
1995 48
1996 71
1997 78
1998 77
1999 104
2000 125
2001 124
2002 119
2003 188
2004 250
2005 266
2006 274
2007 347
2008 328
2009 376
2010 413
2011 508
2012 547
2013 554
2014 530
2015 579
2016 553
2017 559
2018 505
2019 522
2020 584
2021 590
2022 34
Text availability
Article attribute
Article type
Publication date

Search Results

8,712 results
Results by year
Filters applied: . Clear all
Page 1
Immunopathogenesis and treatment of cytokine storm in COVID-19.
Kim JS, Lee JY, Yang JW, Lee KH, Effenberger M, Szpirt W, Kronbichler A, Shin JI. Kim JS, et al. Among authors: lee kh. Theranostics. 2021 Jan 1;11(1):316-329. doi: 10.7150/thno.49713. eCollection 2021. Theranostics. 2021. PMID: 33391477 Free PMC article. Review.
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial.
Faivre-Finn C, Vicente D, Kurata T, Planchard D, Paz-Ares L, Vansteenkiste JF, Spigel DR, Garassino MC, Reck M, Senan S, Naidoo J, Rimner A, Wu YL, Gray JE, Özgüroğlu M, Lee KH, Cho BC, Kato T, de Wit M, Newton M, Wang L, Thiyagarajah P, Antonia SJ. Faivre-Finn C, et al. Among authors: lee kh. J Thorac Oncol. 2021 May;16(5):860-867. doi: 10.1016/j.jtho.2020.12.015. Epub 2021 Jan 19. J Thorac Oncol. 2021. PMID: 33476803 Free article. Clinical Trial.
Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.
Mok TS, Cheng Y, Zhou X, Lee KH, Nakagawa K, Niho S, Chawla A, Rosell R, Corral J, Migliorino MR, Pluzanski A, Noonan K, Tang Y, Pastel M, Wilner KD, Wu YL. Mok TS, et al. Among authors: lee kh. Drugs. 2021 Feb;81(2):257-266. doi: 10.1007/s40265-020-01441-6. Drugs. 2021. PMID: 33331989 Free PMC article. Clinical Trial.
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials.
Han YJ, Lee KH, Yoon S, Nam SW, Ryu S, Seong D, Kim JS, Lee JY, Yang JW, Lee J, Koyanagi A, Hong SH, Dragioti E, Radua J, Smith L, Oh H, Ghayda RA, Kronbichler A, Effenberger M, Kresse D, Denicolò S, Kang W, Jacob L, Shin H, Shin JI. Han YJ, et al. Among authors: lee kh. Theranostics. 2021 Jan 1;11(3):1207-1231. doi: 10.7150/thno.48342. eCollection 2021. Theranostics. 2021. PMID: 33391531 Free PMC article.
Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles.
Lee KH, Kim JS, Hong SH, Seong D, Choi YR, Ahn YT, Kim KS, Kim SE, Lee S, Sim W, Kim D, Jun B, Yang JW, Yon DK, Lee SW, Kim MS, Dragioti E, Li H, Jacob L, Koyanagi A, Abou Ghayda R, Shin JI, Smith L. Lee KH, et al. Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):13089-13097. doi: 10.26355/eurrev_202012_24216. Eur Rev Med Pharmacol Sci. 2020. PMID: 33378062 Free article.
8,712 results